The teaching of pharmacology in medical schools: current status and future perspectives

被引:0
|
作者
Rodriguez-Carranza, Rodolfo [1 ]
y Efrain Campos-Sepulveda, Horacio Vidrio [1 ]
机构
[1] Univ Nacl Autonoma Mexico, Fac Med, Dept Farmacol, Mexico City 04510, DF, Mexico
来源
GACETA MEDICA DE MEXICO | 2008年 / 144卷 / 06期
关键词
Pharmacology; teaching; medical schools; core curricula;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pharmacology is a core course in all medical school curricula. In most medical schools, pharmacology, is taught during the second year and teaching covers both basic aspects and useful drugs for the treatment of human diseases. It is assumed that relevant pharmacologic knowledge is revisited during the clinical clerkships and that students ore adequately trained to prescribe drugs upon graduation. However, for many years it has been noted that pharmacological training is sometimes insufficient and that inadequate and irrational prescription of drugs is a very common problem in clinical settings, Information overload and proliferation of new drugs have been recognized as two of the major contributing factors. To address this issue, many authors have recommended the development of a core curricula in pharmacology which all students would have to complete coupled witha restricted list of drugs. Based on our own teaching experience we have identified what should constitute the core content of pharmacology courses in medical schools and have written a study guide for this discipline. Both documents provide an organizational framework to help second Year medical students ascertain what part of the vast knowledge in pharmacology they need to learn. The number of drugs that students have to manage is limited to 168. Our program constitutes the first effort to medicalize the teaching of pharmacology, in medical schools. We expect that most medical schools will follow our guidelines as our program is applicable to all curricula modalities.
引用
收藏
页码:463 / 472
页数:10
相关论文
共 50 条
  • [31] Immunotherapy: Current Status and Future Perspectives
    Charalampos S. Floudas
    Gagandeep Brar
    Tim F. Greten
    Digestive Diseases and Sciences, 2019, 64 : 1030 - 1040
  • [32] Pharmacogenetics: Current Status and Future Perspectives
    Guchelaar, Henk-Jan
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (02) : 135 - 135
  • [33] UMIN - Current Status and Future Perspectives
    UMIN Center, The University of Tokyo Hospital, Tokyo, Japan
    不详
    International Medical Informatics Association (IMIA), 1879, 1068-1072 (2004):
  • [34] Immunotherapy: Current Status and Future Perspectives
    Floudas, Charalampos S.
    Brar, Gagandeep
    Greten, Tim F.
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (04) : 1030 - 1040
  • [35] Pharmacogenomics: current status and future perspectives
    Munir Pirmohamed
    Nature Reviews Genetics, 2023, 24 : 350 - 362
  • [36] UMIN - Current status and future perspectives
    Kiuchi, T
    Igarashi, T
    MEDINFO 2004: PROCEEDINGS OF THE 11TH WORLD CONGRESS ON MEDICAL INFORMATICS, PT 1 AND 2, 2004, 107 : 1068 - 1072
  • [37] THE ONCOGENES - CURRENT STATUS AND FUTURE PERSPECTIVES
    KOUYOUMDJIAN, JC
    FEUILHADE, F
    RYMER, JC
    RODRIGUES, LEA
    REVISTA BRASILEIRA DE MEDICINA, 1988, 45 (05) : 143 - 149
  • [38] Bedaquiline: Current status and future perspectives
    Khoshnood, Saeed
    Goudarzi, Mehdi
    Taki, Elahe
    Darbandi, Atieh
    Kouhsari, Ebrahim
    Heidary, Mohsen
    Motahar, Moloudsadat
    Moradi, Melika
    Bazyar, Hadi
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 48 - 59
  • [39] TEACHING OF PHARMACOLOGY, CLINICAL PHARMACOLOGY AND THERAPEUTICS IN SPANISH MEDICAL SCHOOLS. PRELIMINARY RESULTS
    Capella, D.
    de Abajo, F.
    de Cosa, L.
    Mediavilla, A.
    Payares, C.
    Portoles, A.
    Morros-Pedros, R.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : E17 - E17
  • [40] Current practices in medical Spanish teaching in US medical schools
    Maben, K
    Dobbie, A
    FAMILY MEDICINE, 2005, 37 (09) : 613 - 614